INTRODUCTION
In December 2019, Wuhan, the capital of China’s Hubei region, began to
experience cases of pneumonia that did not respond to standard
treatments. A new coronavirus called SARS-CoV-2 was detected as the
cause of the disease 1. The SARS-CoV-2 is a
β-coronavirus, which is enveloped non-segmented positive-sense RNA virus2. The disease spread rapidly worldwide. On March 11,
2020, the world health organization (WHO) declared that this was a
pandemic 3. In Turkey until the date August 09, 2020,
the number of confirmed cases was 240 804, and the number of recovered
cases were 223 759. The number of patients who died due to the virus was
5844. The COVID-19 disease is highly contagious and can rapidly progress
to Acute respiratory distress syndrome (ARDS), leading to death4,5. Older men with comorbidity are more likely to
have respiratory failure, and some patients have made rapid progress to
multi-organ dysfunction 6. The Centers for Disease
Control and Prevention (CDC) recommends that after two negative
respiratory tests separated by ≥ 24 hours, patients can be dismissed
from having transmissibility infection risk for COVID-19. In laboratory
examination results, most patients had normal or decreased white blood
cell counts, and lymphocytopenia 7,8.
CT findings are critical in the diagnosis of COVID-19 disease. The
imaging findings of COVID-19 disease are not specific and variable.
However, most common findings are round pulmonary parenchymal
ground-glass opacities without lung cavitation, separate pulmonary
nodules or pleural effusion 9. Other less common
imaging features include linear densities, pavement pattern, bronchial
wall thickening and reverse halo sign 10.
In this study, we aimed to present patients who admitted to our urology
outpatient clinic with a complaint of flank pain during the pandemic
process and incidentally have ground-glass densities compatible with
COVID-19 in basal lung sections on abdomen CT images.